Press Release

Hayward, CA, USA, March 15, 2017 – Moximed®, Inc., developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis (OA), announced today an oversubscribed Series C round of $50MM with new investors Advent Life Sciences and Future Fund joining existing investors NEA,...

Moximed announces CE Mark of the Atlas Knee System, its next-generation knee joint unloader for pre-arthroplasty patients. Coinciding with the CE Mark was the first commercial uses of the product. View online | Download PDF...

Moximed®, the developer of the KineSpring® System, a joint unloading knee implant for pre-arthroplasty patients, has been named by FierceMedicalDevices as one of 2015’s Fierce 15. View online | Download PDF...